XOMA Royalty Corporation (XOMA)
- Previous Close
29.40 - Open
29.47 - Bid --
- Ask --
- Day's Range
28.40 - 29.47 - 52 Week Range
14.27 - 30.50 - Volume
9,580 - Avg. Volume
22,306 - Market Cap (intraday)
333.11M - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
-- - EPS (TTM)
-2.20 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield 2.16 (7.58%)
- Ex-Dividend Date Apr 2, 2024
- 1y Target Est
83.00
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
xoma.comRecent News: XOMA
View More
Performance Overview: XOMA
Trailing total returns as of 10/21/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XOMA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XOMA
View MoreValuation Measures
Market Cap
333.11M
Enterprise Value
310.48M
Trailing P/E
--
Forward P/E
188.68
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
41.70
Price/Book (mrq)
3.33
Enterprise Value/Revenue
31.66
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-119.61%
Return on Assets (ttm)
-6.62%
Return on Equity (ttm)
-17.35%
Revenue (ttm)
15.24M
Net Income Avi to Common (ttm)
-25.1M
Diluted EPS (ttm)
-2.20
Balance Sheet and Cash Flow
Total Cash (mrq)
144.6M
Total Debt/Equity (mrq)
121.93%
Levered Free Cash Flow (ttm)
-10.5M
Research Analysis: XOMA
View MoreCompany Insights: XOMA
XOMA does not have Company Insights
Research Reports: XOMA
View MoreDaily – Vickers Top Buyers & Sellers for 09/28/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/19/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 04/05/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.